We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Empirical and Rational Design of T Cell Receptor-Based Immunotherapies.
- Authors
Jones, Heather F.; Molvi, Zaki; Klatt, Martin G.; Dao, Tao; Scheinberg, David A.
- Abstract
The use of T cells reactive with intracellular tumor-associated or tumor-specific antigens has been a promising strategy for cancer immunotherapies in the past three decades, but the approach has been constrained by a limited understanding of the T cell receptor's (TCR) complex functions and specificities. Newer TCR and T cell-based approaches are in development, including engineered adoptive T cells with enhanced TCR affinities, TCR mimic antibodies, and T cell-redirecting bispecific agents. These new therapeutic modalities are exciting opportunities by which TCR recognition can be further exploited for therapeutic benefit. In this review we summarize the development of TCR-based therapeutic strategies and focus on balancing efficacy and potency versus specificity, and hence, possible toxicity, of these powerful therapeutic modalities.
- Subjects
T cells; T cell receptors; IMMUNOTHERAPY
- Publication
Frontiers in Immunology, 2021, Vol 11, pN.PAG
- ISSN
1664-3224
- Publication type
Article
- DOI
10.3389/fimmu.2020.585385